Stockscreener 앱 받기
18.38
2.91%
0.52
시간 외 거래:
18.26
-0.12
-0.65%
Erasca Inc 주식(ERAS)의 최신 뉴스
Does Legal Scrutiny And Leadership Change Reshape The Bull Case For Erasca’s ERAS-0015 Program (ERAS)? - simplywall.st
ERAS STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
ERAS Stock Slumps Nearly 40% After-Hours: Fine Print In 'Positive' Cancer Trial Reveals Treatment-Related Death - Stocktwits
Erasca (ERAS) insiders report 10.4% and 5.6% ownership stakes - Stock Titan
ERAS Maintained by B of A Securities -- Price Target Raised to $20 - GuruFocus
Bank of America Issues Positive Forecast for Erasca (NASDAQ:ERAS) Stock Price - MarketBeat
Erasca, Inc. Stock 12‑Month Price Target Raised to $23, Implies 29% Upside - TradingView
Attention Long-Term Shareholders of ARS Pharmaceuticals, - globenewswire.com
HC Wainwright Has Negative Estimate for Erasca Q3 Earnings - MarketBeat
BofA Adjusts Price Target on Erasca to $20 From $18 - marketscreener.com
Erasca, Inc. (NASDAQ:ERAS) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Guggenheim raises Erasca stock price target to $21 on pipeline progress - Investing.com South Africa
Erasca Awards 1.3 Million Stock Options to New President of R&D - Kalkine Media
Erasca, Inc. Stock 12‑Month Price Target Raised to $22.82, Implies 25% Upside - TradingView
Erasca, Inc. Stock 12‑Month Price Target Raised to $22.73, Implies 24% Upside - TradingView
Propanc Biopharma Highlights Differentiated Proenzyme Therapy PRP as a Potential Therapy of Choice Against RAS-Driven Cancers - The Manila Times
Erasca (NASDAQ:ERAS) Given New $22.00 Price Target at HC Wainwright - MarketBeat
H.C. Wainwright raises Erasca stock price target on trial progress By Investing.com - Investing.com South Africa
H.C. Wainwright raises Erasca stock price target on trial progress - Investing.com
ERAS Maintained by HC Wainwright & Co. -- Price Target Raised to $22 - GuruFocus
Bank of America Corp DE Raises Position in Erasca, Inc. $ERAS - MarketBeat
Erasca (NASDAQ:ERAS) Announces Earnings Results, Misses Expectations By $0.03 EPS - MarketBeat
Erasca Q2 EPS of $(0.14) misses $(0.11) estimate on R&D spend - scanx.trade
Earnings Flash (ERAS) Erasca Posts Q2 Loss $0.14 per Share, vs. FactSet Est of $0.11 Loss - marketscreener.com
Erasca, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
ERAS: ERAS-0015 delivers strong efficacy and safety in RAS-mutant cancers, advancing toward pivotal trials - TradingView
Erasca Reports Second Quarter 2026 Business Updates and Financial Results - The Manila Times
Erasca, Inc. 2Q 2026: Net income $(44.1M), EPS $(0.14) — 10-Q Summary - TradingView
Erasca (ERAS) boosts cash by $836M while advancing RAS oncology pipeline - Stock Titan
Erasca, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Important Notice to Long-Term Shareholders of Erasca, Inc. - GlobeNewswire
ERAS DEADLINEFINAL REMINDER: Bronstein, Gewirtz and Grossman, LLC Announces that Erasca, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
812,876 Shares in Erasca, Inc. $ERAS Acquired by Assenagon Asset Management S.A. - MarketBeat
Erasca appoints Charles Fuchs as R&D president By Investing.com - Investing.com India
Erasca Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Press Release: Erasca Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Moomoo
Bronstein, Gewirtz & Grossman LLC Urges Erasca, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit with SBS Law - Business Wire
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Eras - GuruFocus
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Erasca (ERAS) Investors of Securities Class Action Lawsuit Deadline on August 10, 2026 - 巴士的報
Erasca appoints Charles Fuchs as R&D president - Investing.com
Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action LawsuitContact Reed Kathrein at Hagens Berman Sobol Shapiro LLP By Application Deadline - PR Newswire
Erasca Strengthens R&D Leadership with Appointment of Internationally Recognized Medical Oncologist Charles S. Fuchs, M.D., M.P.H., as President of R&D - The Manila Times
Erasca, Inc. Announces Appointment of Charles S. Fuchs as President of Research and Development, Effective on August 10, 2026 - marketscreener.com
California State Teachers Retirement System Grows Position in Erasca, Inc. $ERAS - MarketBeat
Kaplan Fox Alerts Erasca, Inc. (NASDAQ: ERAS) Investors to Seek L - The National Law Review
ERAS DEADLINE REMINDER: Bronstein, Gewirtz & Grossman LLC Alerts Erasca, Inc. Investors to Participate in the Class Action Lawsuit Today - ACCESS Newswire
ERAS DEADLINE REMINDER: Bronstein, Gewirtz & Grossman LLC Alerts - The National Law Review
ERAS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
Erasca 48 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Erasca, Inc.ERAS - ACCESS Newswire
ERASCA DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Erasca, Inc. Investors to Secure ... - Caledonian Record
ERASCA DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, - globenewswire.com
ERAS SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Erasca (ERAS) Investors of Securities Class Action Lawsuit Deadline on August 10, 2026 - ACCESS Newswire
The Manufacturers Life Insurance Company Acquires 161,845 Shares of Erasca, Inc. $ERAS - MarketBeat
ERAS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
ERAS STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Erasca, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Erasca 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Erasca, Inc.ERAS - Business Wire
ERASCA LEAD PLAINTIFF DEADLINE AUGUST 10th: Bragar Eagel & - GlobeNewswire
0.52%
0.07%
자본화:
|
볼륨(24시간):